This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Digital Breast Tomosynthesis in Younger Symptomatic Women

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
University of Dundee
Information provided by (Responsible Party):
Andy Evans, NHS Tayside
ClinicalTrials.gov Identifier:
NCT01241981
First received: November 15, 2010
Last updated: April 26, 2017
Last verified: April 2017
  Purpose
This study will examine a new imaging technique called digital breast tomosynthesis (DBT) compared to standard mammography in women under 60 presenting with signs of breast cancer. The reason that we need to do this study is that standard mammography fails to detect the cancer in approximately 20% of these women because younger women have denser breast tissue. We hope that DBT will be more sensitive in detecting breast cancer than standard mammography.

Condition
Breast Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Digital Breast Tomosynthesis (DBT): Sensitivity for Cancer and Accuracy in Assessing Extent of Malignant Disease in Symptomatic Women Below 60 With Clinical or Ultrasound Signs Compatible With Malignancy

Resource links provided by NLM:


Further study details as provided by Andy Evans, NHS Tayside:

Primary Outcome Measures:
  • Sensitivity of DBT for breast cancer, compared with FFDM [ Time Frame: Two years ]

Secondary Outcome Measures:
  • Accuracy of DBT compared with FFDM in assessment of tumour extent [ Time Frame: Two years ]
  • Relative accuracy of DBT and FFDM by breast density [ Time Frame: Two years ]

Enrollment: 446
Study Start Date: March 2011
Estimated Study Completion Date: July 2017
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Digital Breast Tomosynthesis
Digital Breast Tomosynthesis

  Eligibility

Ages Eligible for Study:   up to 59 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Women under 60 years of age with clinical or ultrasound suspicion of breast cancer
Criteria

Inclusion Criteria:

  • Female
  • Under 60 years old
  • Clinical or ultrasound suspicion of breast cancer

Exclusion Criteria:

  • Unable to give informed consent
  • Male
  • Obvious advanced breast cancer
  • Obvious medical problems meaning surgery would not be an option
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01241981

Locations
United Kingdom
NHS Tayside, Ninewells Hospital & Medical School
Dundee, Tayside, United Kingdom, DD1 9SY
Sponsors and Collaborators
NHS Tayside
University of Dundee
Investigators
Principal Investigator: Andrew J Evans, FRCR University of Dundee, NHS Tayside
  More Information

Responsible Party: Andy Evans, Professor of Breast Imaging, NHS Tayside
ClinicalTrials.gov Identifier: NCT01241981     History of Changes
Other Study ID Numbers: 2010ON15
Study First Received: November 15, 2010
Last Updated: April 26, 2017

Keywords provided by Andy Evans, NHS Tayside:
Breast
Cancer
Digital
Mammography
Tomosynthesis

ClinicalTrials.gov processed this record on August 23, 2017